Amgen IncChange company Symbol lookupSelect an option...AMGN Amgen IncAPLS Apellis Pharmaceuticals IncAMD Advanced Micro Devices IncOTIS Otis Worldwide CorpGME GameStop CorpECF Ellsworth Growth and Income Fund LtdSILK Silk Road Medical IncHLVX Hillevax IncAIZ Assurant IncNOTV Inotiv IncGo
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.
Premarket |
|
|
| ||
Market Hours |
|
|
|
|
|
Upcoming Events
- FEB
14
2023 - Ex-dividend Date
- Dividend amount
$2.13 - Record date
February 15, 2023 - Pay date
March 8, 2023
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| January 31, 2023 | Q4 2022 Earnings Release | $4.09 | $3.94 to $4.25 | $4.36 |
| November 3, 2022 | Q3 2022 Earnings Release | $4.70 | $4.23 to $4.75 | $4.67 |
| August 4, 2022 | Q2 2022 Earnings Release | $4.65 | $3.95 to $4.87 | $4.38 |
| April 27, 2022 | Q1 2022 Earnings Release | $4.25 | $3.70 to $4.67 | $3.70 |
| February 7, 2022 | Q4 2021 Earnings Release | $4.36 | $3.66 to $5.08 | -- |
Past Dividends
| Ex-dividend date | Amount | Record date | Pay date |
|---|---|---|---|
| November 16, 2022 | $1.94 | November 17, 2022 | December 8, 2022 |
| August 17, 2022 | $1.94 | August 18, 2022 | September 8, 2022 |
| May 16, 2022 | $1.94 | May 17, 2022 | June 8, 2022 |
| February 14, 2022 | $1.94 | February 15, 2022 | March 8, 2022 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.